Global Drug Safety Solutions and Pharmacovigilance Market Size, Status and Forecast 2024-2031

Report ID: 920534 | Published Date: May 2024 | No. of Page: 126 | Base Year: 2023 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Standard Form
        1.2.3 Customized Form
    1.3 Market by Application
        1.3.1 Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Biotechnology and Pharmaceuticals
        1.3.3 Contract Research Organization (CROS)
        1.3.4 Hospital
        1.3.5 KPO / BPO
        1.3.6 Healthcare Institutions
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Drug Safety Solutions and Pharmacovigilance Market Perspective (2016-2027)
    2.2 Drug Safety Solutions and Pharmacovigilance Growth Trends by Regions
        2.2.1 Drug Safety Solutions and Pharmacovigilance Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Drug Safety Solutions and Pharmacovigilance Historic Market Share by Regions (2016-2021)
        2.2.3 Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Regions (2022-2027)
    2.3 Drug Safety Solutions and Pharmacovigilance Industry Dynamic
        2.3.1 Drug Safety Solutions and Pharmacovigilance Market Trends
        2.3.2 Drug Safety Solutions and Pharmacovigilance Market Drivers
        2.3.3 Drug Safety Solutions and Pharmacovigilance Market Challenges
        2.3.4 Drug Safety Solutions and Pharmacovigilance Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue
        3.1.1 Global Top Drug Safety Solutions and Pharmacovigilance Players by Revenue (2016-2021)
        3.1.2 Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Players (2016-2021)
    3.2 Global Drug Safety Solutions and Pharmacovigilance Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Drug Safety Solutions and Pharmacovigilance Revenue
    3.4 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio
        3.4.1 Global Drug Safety Solutions and Pharmacovigilance Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Solutions and Pharmacovigilance Revenue in 2020
    3.5 Drug Safety Solutions and Pharmacovigilance Key Players Head office and Area Served
    3.6 Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service
    3.7 Date of Enter into Drug Safety Solutions and Pharmacovigilance Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Type
    4.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Type (2016-2021)
    4.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2022-2027)

5 Drug Safety Solutions and Pharmacovigilance Breakdown Data by Application
    5.1 Global Drug Safety Solutions and Pharmacovigilance Historic Market Size by Application (2016-2021)
    5.2 Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Drug Safety Solutions and Pharmacovigilance Market Size (2016-2027)
    6.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type
        6.2.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021)
        6.2.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027)
        6.2.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2027)
    6.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application
        6.3.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021)
        6.3.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027)
        6.3.3 North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2027)
    6.4 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country
        6.4.1 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021)
        6.4.2 North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size (2016-2027)
    7.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type
        7.2.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021)
        7.2.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027)
        7.2.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2027)
    7.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application
        7.3.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021)
        7.3.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027)
        7.3.3 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2027)
    7.4 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country
        7.4.1 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021)
        7.4.2 Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size (2016-2027)
    8.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Type
        8.2.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2027)
    8.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Application
        8.3.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2027)
    8.4 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region
        8.4.1 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size (2016-2027)
    9.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type
        9.2.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021)
        9.2.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027)
        9.2.3 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2027)
    9.3 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application
        9.3.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021)
        9.3.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027)
        9.3.3 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2027)
    9.4 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country
        9.4.1 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021)
        9.4.2 Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size (2016-2027)
    10.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Type
        10.2.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2027)
    10.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Application
        10.3.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2027)
    10.4 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country
        10.4.1 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Pharmaceutical Product Development, LLC
        11.1.1 Pharmaceutical Product Development, LLC Company Details
        11.1.2 Pharmaceutical Product Development, LLC Business Overview
        11.1.3 Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Introduction
        11.1.4 Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.1.5 Pharmaceutical Product Development, LLC Recent Development
    11.2 Drug Safety Solutions Limited
        11.2.1 Drug Safety Solutions Limited Company Details
        11.2.2 Drug Safety Solutions Limited Business Overview
        11.2.3 Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Introduction
        11.2.4 Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.2.5 Drug Safety Solutions Limited Recent Development
    11.3 C3i
        11.3.1 C3i Company Details
        11.3.2 C3i Business Overview
        11.3.3 C3i Drug Safety Solutions and Pharmacovigilance Introduction
        11.3.4 C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.3.5 C3i Recent Development
    11.4 Worldwide Clinical Trials
        11.4.1 Worldwide Clinical Trials Company Details
        11.4.2 Worldwide Clinical Trials Business Overview
        11.4.3 Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Introduction
        11.4.4 Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.4.5 Worldwide Clinical Trials Recent Development
    11.5 Bioclinica
        11.5.1 Bioclinica Company Details
        11.5.2 Bioclinica Business Overview
        11.5.3 Bioclinica Drug Safety Solutions and Pharmacovigilance Introduction
        11.5.4 Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.5.5 Bioclinica Recent Development
    11.6 United Biosource LLC
        11.6.1 United Biosource LLC Company Details
        11.6.2 United Biosource LLC Business Overview
        11.6.3 United Biosource LLC Drug Safety Solutions and Pharmacovigilance Introduction
        11.6.4 United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.6.5 United Biosource LLC Recent Development
    11.7 Ennov
        11.7.1 Ennov Company Details
        11.7.2 Ennov Business Overview
        11.7.3 Ennov Drug Safety Solutions and Pharmacovigilance Introduction
        11.7.4 Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.7.5 Ennov Recent Development
    11.8 AB Cube
        11.8.1 AB Cube Company Details
        11.8.2 AB Cube Business Overview
        11.8.3 AB Cube Drug Safety Solutions and Pharmacovigilance Introduction
        11.8.4 AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.8.5 AB Cube Recent Development
    11.9 Covance Inc.
        11.9.1 Covance Inc. Company Details
        11.9.2 Covance Inc. Business Overview
        11.9.3 Covance Inc. Drug Safety Solutions and Pharmacovigilance Introduction
        11.9.4 Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.9.5 Covance Inc. Recent Development
    11.10 Accenture
        11.10.1 Accenture Company Details
        11.10.2 Accenture Business Overview
        11.10.3 Accenture Drug Safety Solutions and Pharmacovigilance Introduction
        11.10.4 Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.10.5 Accenture Recent Development
    11.11 PRA Health Sciences, Inc.
        11.11.1 PRA Health Sciences, Inc. Company Details
        11.11.2 PRA Health Sciences, Inc. Business Overview
        11.11.3 PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Introduction
        11.11.4 PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.11.5 PRA Health Sciences, Inc. Recent Development
    11.12 Ergomed
        11.12.1 Ergomed Company Details
        11.12.2 Ergomed Business Overview
        11.12.3 Ergomed Drug Safety Solutions and Pharmacovigilance Introduction
        11.12.4 Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.12.5 Ergomed Recent Development
    11.13 IQVIA
        11.13.1 IQVIA Company Details
        11.13.2 IQVIA Business Overview
        11.13.3 IQVIA Drug Safety Solutions and Pharmacovigilance Introduction
        11.13.4 IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.13.5 IQVIA Recent Development
    11.14 Genpact
        11.14.1 Genpact Company Details
        11.14.2 Genpact Business Overview
        11.14.3 Genpact Drug Safety Solutions and Pharmacovigilance Introduction
        11.14.4 Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.14.5 Genpact Recent Development
    11.15 Cognizant
        11.15.1 Cognizant Company Details
        11.15.2 Cognizant Business Overview
        11.15.3 Cognizant Drug Safety Solutions and Pharmacovigilance Introduction
        11.15.4 Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.15.5 Cognizant Recent Development
    11.16 Parexel International Corporation
        11.16.1 Parexel International Corporation Company Details
        11.16.2 Parexel International Corporation Business Overview
        11.16.3 Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Introduction
        11.16.4 Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.16.5 Parexel International Corporation Recent Development
    11.17 ArisGlobal
        11.17.1 ArisGlobal Company Details
        11.17.2 ArisGlobal Business Overview
        11.17.3 ArisGlobal Drug Safety Solutions and Pharmacovigilance Introduction
        11.17.4 ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.17.5 ArisGlobal Recent Development
    11.18 ICON plc
        11.18.1 ICON plc Company Details
        11.18.2 ICON plc Business Overview
        11.18.3 ICON plc Drug Safety Solutions and Pharmacovigilance Introduction
        11.18.4 ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.18.5 ICON plc Recent Development
    11.18 Oracle
        .1 Oracle Company Details
        .2 Oracle Business Overview
        .3 Oracle Drug Safety Solutions and Pharmacovigilance Introduction
        .4 Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        .5 Oracle Recent Development
    11.20 Syneos Health
        11.20.1 Syneos Health Company Details
        11.20.2 Syneos Health Business Overview
        11.20.3 Syneos Health Drug Safety Solutions and Pharmacovigilance Introduction
        11.20.4 Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
        11.20.5 Syneos Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Standard Form
    Table 3. Key Players of Customized Form
    Table 4. Global Drug Safety Solutions and Pharmacovigilance Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Drug Safety Solutions and Pharmacovigilance Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Drug Safety Solutions and Pharmacovigilance Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions (2016-2021)
    Table 8. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions (2022-2027)
    Table 10. Drug Safety Solutions and Pharmacovigilance Market Trends
    Table 11. Drug Safety Solutions and Pharmacovigilance Market Drivers
    Table 12. Drug Safety Solutions and Pharmacovigilance Market Challenges
    Table 13. Drug Safety Solutions and Pharmacovigilance Market Restraints
    Table 14. Global Drug Safety Solutions and Pharmacovigilance Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players (2016-2021)
    Table 16. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2020)
    Table 17. Ranking of Global Top Drug Safety Solutions and Pharmacovigilance Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Drug Safety Solutions and Pharmacovigilance Product Solution and Service
    Table 21. Date of Enter into Drug Safety Solutions and Pharmacovigilance Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2016-2021)
    Table 25. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Drug Safety Solutions and Pharmacovigilance Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2016-2021)
    Table 29. Global Drug Safety Solutions and Pharmacovigilance Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Pharmaceutical Product Development, LLC Company Details
    Table 62. Pharmaceutical Product Development, LLC Business Overview
    Table 63. Pharmaceutical Product Development, LLC Drug Safety Solutions and Pharmacovigilance Product
    Table 64. Pharmaceutical Product Development, LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 65. Pharmaceutical Product Development, LLC Recent Development
    Table 66. Drug Safety Solutions Limited Company Details
    Table 67. Drug Safety Solutions Limited Business Overview
    Table 68. Drug Safety Solutions Limited Drug Safety Solutions and Pharmacovigilance Product
    Table 69. Drug Safety Solutions Limited Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 70. Drug Safety Solutions Limited Recent Development
    Table 71. C3i Company Details
    Table 72. C3i Business Overview
    Table 73. C3i Drug Safety Solutions and Pharmacovigilance Product
    Table 74. C3i Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 75. C3i Recent Development
    Table 76. Worldwide Clinical Trials Company Details
    Table 77. Worldwide Clinical Trials Business Overview
    Table 78. Worldwide Clinical Trials Drug Safety Solutions and Pharmacovigilance Product
    Table 79. Worldwide Clinical Trials Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 80. Worldwide Clinical Trials Recent Development
    Table 81. Bioclinica Company Details
    Table 82. Bioclinica Business Overview
    Table 83. Bioclinica Drug Safety Solutions and Pharmacovigilance Product
    Table 84. Bioclinica Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 85. Bioclinica Recent Development
    Table 86. United Biosource LLC Company Details
    Table 87. United Biosource LLC Business Overview
    Table 88. United Biosource LLC Drug Safety Solutions and Pharmacovigilance Product
    Table 89. United Biosource LLC Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 90. United Biosource LLC Recent Development
    Table 91. Ennov Company Details
    Table 92. Ennov Business Overview
    Table 93. Ennov Drug Safety Solutions and Pharmacovigilance Product
    Table 94. Ennov Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 95. Ennov Recent Development
    Table 96. AB Cube Company Details
    Table 97. AB Cube Business Overview
    Table 98. AB Cube Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 99. AB Cube Recent Development
    Table 100. Covance Inc. Company Details
    Table 101. Covance Inc. Business Overview
    Table 102. Covance Inc. Drug Safety Solutions and Pharmacovigilance Product
    Table 103. Covance Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 104. Covance Inc. Recent Development
    Table 105. Accenture Company Details
    Table 106. Accenture Business Overview
    Table 107. Accenture Drug Safety Solutions and Pharmacovigilance Product
    Table 108. Accenture Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 109. Accenture Recent Development
    Table 110. PRA Health Sciences, Inc. Company Details
    Table 111. PRA Health Sciences, Inc. Business Overview
    Table 112. PRA Health Sciences, Inc. Drug Safety Solutions and Pharmacovigilance Product
    Table 113. PRA Health Sciences, Inc. Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 114. PRA Health Sciences, Inc. Recent Development
    Table 115. Ergomed Company Details
    Table 116. Ergomed Business Overview
    Table 117. Ergomed Drug Safety Solutions and Pharmacovigilance Product
    Table 118. Ergomed Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 119. Ergomed Recent Development
    Table 120. IQVIA Company Details
    Table 121. IQVIA Business Overview
    Table 122. IQVIA Drug Safety Solutions and Pharmacovigilance Product
    Table 123. IQVIA Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 124. IQVIA Recent Development
    Table 125. Genpact Company Details
    Table 126. Genpact Business Overview
    Table 127. Genpact Drug Safety Solutions and Pharmacovigilance Product
    Table 128. Genpact Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 129. Genpact Recent Development
    Table 130. Cognizant Company Details
    Table 131. Cognizant Business Overview
    Table 132. Cognizant Drug Safety Solutions and Pharmacovigilance Product
    Table 133. Cognizant Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 134. Cognizant Recent Development
    Table 135. Parexel International Corporation Company Details
    Table 136. Parexel International Corporation Business Overview
    Table 137. Parexel International Corporation Drug Safety Solutions and Pharmacovigilance Product
    Table 138. Parexel International Corporation Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 139. Parexel International Corporation Recent Development
    Table 140. ArisGlobal Company Details
    Table 141. ArisGlobal Business Overview
    Table 142. ArisGlobal Drug Safety Solutions and Pharmacovigilance Product
    Table 143. ArisGlobal Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 144. ArisGlobal Recent Development
    Table 145. ICON plc Company Details
    Table 146. ICON plc Business Overview
    Table 147. ICON plc Drug Safety Solutions and Pharmacovigilance Product
    Table 148. ICON plc Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 149. ICON plc Recent Development
    Table 150. Oracle Company Details
    Table 151. Oracle Business Overview
    Table 152. Oracle Drug Safety Solutions and Pharmacovigilance Product
    Table 153. Oracle Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 154. Oracle Recent Development
    Table 155. Syneos Health Company Details
    Table 156. Syneos Health Business Overview
    Table 157. Syneos Health Drug Safety Solutions and Pharmacovigilance Product
    Table 158. Syneos Health Revenue in Drug Safety Solutions and Pharmacovigilance Business (2016-2021) & (US$ Million)
    Table 159. Syneos Health Recent Development
    Table 160. Research Programs/Design for This Report
    Table 161. Key Data Information from Secondary Sources
    Table 162. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug Safety Solutions and Pharmacovigilance Market Share by Type: 2020 VS 2027
    Figure 2. Standard Form Features
    Figure 3. Customized Form Features
    Figure 4. Global Drug Safety Solutions and Pharmacovigilance Market Share by Application: 2020 VS 2027
    Figure 5. Biotechnology and Pharmaceuticals Case Studies
    Figure 6. Contract Research Organization (CROS) Case Studies
    Figure 7. Hospital Case Studies
    Figure 8. KPO / BPO Case Studies
    Figure 9. Healthcare Institutions Case Studies
    Figure 10. Others Case Studies
    Figure 11. Drug Safety Solutions and Pharmacovigilance Report Years Considered
    Figure 12. Global Drug Safety Solutions and Pharmacovigilance Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Drug Safety Solutions and Pharmacovigilance Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions: 2020 VS 2027
    Figure 15. Global Drug Safety Solutions and Pharmacovigilance Market Share by Regions (2022-2027)
    Figure 16. Global Drug Safety Solutions and Pharmacovigilance Market Share by Players in 2020
    Figure 17. Global Top Drug Safety Solutions and Pharmacovigilance Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Safety Solutions and Pharmacovigilance as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Drug Safety Solutions and Pharmacovigilance Revenue in 2020
    Figure 19. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2016-2021)
    Figure 20. Global Drug Safety Solutions and Pharmacovigilance Revenue Market Share by Type (2022-2027)
    Figure 21. North America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2016-2027)
    Figure 23. North America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2016-2027)
    Figure 24. North America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2016-2027)
    Figure 25. United States Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Type (2016-2027)
    Figure 29. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Application (2016-2027)
    Figure 30. Europe Drug Safety Solutions and Pharmacovigilance Market Share by Country (2016-2027)
    Figure 31. Germany Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Drug Safety Solutions and Pharmacovigilance Market Share by Region (2016-2027)
    Figure 41. China Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Type (2016-2027)
    Figure 49. Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Application (2016-2027)
    Figure 50. Latin America Drug Safety Solutions and Pharmacovigilance Market Share by Country (2016-2027)
    Figure 51. Mexico Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Drug Safety Solutions and Pharmacovigilance Market Share by Country (2016-2027)
    Figure 57. Turkey Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Drug Safety Solutions and Pharmacovigilance Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Pharmaceutical Product Development, LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 61. Drug Safety Solutions Limited Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 62. C3i Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 63. Worldwide Clinical Trials Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 64. Bioclinica Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 65. United Biosource LLC Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 66. Ennov Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 67. AB Cube Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 68. Covance Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 69. Accenture Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 70. PRA Health Sciences, Inc. Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 71. Ergomed Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 72. IQVIA Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 73. Genpact Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 74. Cognizant Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 75. Parexel International Corporation Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 76. ArisGlobal Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 77. ICON plc Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 78. Oracle Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 79. Syneos Health Revenue Growth Rate in Drug Safety Solutions and Pharmacovigilance Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pharmaceutical Product Development, LLC
Drug Safety Solutions Limited
C3i
Worldwide Clinical Trials
Bioclinica
United Biosource LLC
Ennov
AB Cube
Covance Inc.
Accenture
PRA Health Sciences, Inc.
Ergomed
IQVIA
Genpact
Cognizant
Parexel International Corporation
ArisGlobal
ICON plc
Oracle
Syneos Health
Frequently Asked Questions
Drug Safety Solutions and Pharmacovigilance report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug Safety Solutions and Pharmacovigilance report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug Safety Solutions and Pharmacovigilance report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports